2019
DOI: 10.1002/pon.5202
|View full text |Cite
|
Sign up to set email alerts
|

Cognitive functioning following brain irradiation as part of cancer treatment: Characterizing better cognitive performance

Abstract: Objective Although brain radiation therapy (RT) impacts cognitive function, little is known about the subset of survivors with minimal cognitive deficits. This study compares the characteristics of patients receiving brain irradiation as part of cancer treatment with minimal cognitive deficits to those with poorer cognitive functioning. Methods Adults at least 6 months postbrain RT (N = 198) completed cognitive measures of attention, memory, and executive functions. Cognitive functioning was categorized into b… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
16
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(16 citation statements)
references
References 38 publications
0
16
0
Order By: Relevance
“…We further excluded 106 publications based on the exclusion criteria. Finally, 23 studies describing the development of prediction models were included, of which 16 ( Gregor et al, 1996 ; Blay et al, 1998 ; Klein et al, 2002 ; Kaleita et al, 2004 ; van Beek et al, 2007 ; Wang et al, 2010 ; Starke et al, 2011 ; Gondi et al, 2012 ; Kangas et al, 2012 ; Chapman et al, 2016 ; Wong et al, 2019 ; Dutz et al, 2020 ; Gui et al, 2020 ; Tibbs et al, 2020 ; Langegård et al, 2021 ; Zamanipoor Najafabadi et al, 2021 ) studies included patients with primary and 7 ( Wolfson et al, 2011 ; Gondi et al, 2013 ; Nakazaki and Kano, 2013 ; Chen et al, 2017 ; Yamamoto et al, 2017 ; Gui et al, 2019 ; Brown et al, 2020 ) with metastatic brain tumors. No external validation studies were identified.…”
Section: Resultsmentioning
confidence: 99%
“…We further excluded 106 publications based on the exclusion criteria. Finally, 23 studies describing the development of prediction models were included, of which 16 ( Gregor et al, 1996 ; Blay et al, 1998 ; Klein et al, 2002 ; Kaleita et al, 2004 ; van Beek et al, 2007 ; Wang et al, 2010 ; Starke et al, 2011 ; Gondi et al, 2012 ; Kangas et al, 2012 ; Chapman et al, 2016 ; Wong et al, 2019 ; Dutz et al, 2020 ; Gui et al, 2020 ; Tibbs et al, 2020 ; Langegård et al, 2021 ; Zamanipoor Najafabadi et al, 2021 ) studies included patients with primary and 7 ( Wolfson et al, 2011 ; Gondi et al, 2013 ; Nakazaki and Kano, 2013 ; Chen et al, 2017 ; Yamamoto et al, 2017 ; Gui et al, 2019 ; Brown et al, 2020 ) with metastatic brain tumors. No external validation studies were identified.…”
Section: Resultsmentioning
confidence: 99%
“…We further excluded 106 publications based on the exclusion criteria. Finally, 23 studies describing the development of prediction models were included, of which 16 [19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34] studies included patients with primary and 7 [35][36][37][38][39][40][41] with metastatic brain tumors. No external validation studies were identi ed.…”
Section: General Characteristics Of Included Studiesmentioning
confidence: 99%
“…Regarding the data source, retrospective cohort was the most popular study design used for nine studies [19,20,23,27,31,33,34,37,39], followed by prospective cohort (seven studies) [21,22,25,26,28,30,38], and prospective trials (seven studies) [24,29,32,35,36,40,41]. The median sample size of the cohorts was 81 (IQR=54-266) and the median incidence of neurocognitive toxicity for studies with binary outcome was 26% (IQR=14%-73%).…”
Section: General Characteristics Of Included Studiesmentioning
confidence: 99%
See 2 more Smart Citations